Comparing Alternative Ranibizumab Dosages for Safety and Efficacy in Retinopathy of Prematurity

Andreas Stahl, Tim U. Krohne, Nicole Eter, Isabel Oberacher-Velten, Rainer Guthoff, Synke Meltendorf, Oliver Ehrt, Sabine Aisenbrey, Johann Roider, Heinrich Gerding, Claudia Jandeck, Lois E. H. Smith, Johanna M. Walz, Unknown

Open source

DOI
10.1001/jamapediatrics.2017.4838
Published
2018-03-01
Container
JAMA Pediatrics
Publisher
American Medical Association (AMA)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1001/jamapediatrics.2017.4838,
  title = {Comparing Alternative Ranibizumab Dosages for Safety and Efficacy in Retinopathy of Prematurity},
  author = {Andreas Stahl and Tim U. Krohne and Nicole Eter and Isabel Oberacher-Velten and Rainer Guthoff and Synke Meltendorf and Oliver Ehrt and Sabine Aisenbrey and Johann Roider and Heinrich Gerding and Claudia Jandeck and Lois E. H. Smith and Johanna M. Walz and Unknown},
  year = {2018},
  journal = {JAMA Pediatrics},
  doi = {10.1001/jamapediatrics.2017.4838},
  url = {https://doi.org/10.1001/jamapediatrics.2017.4838}
}

RIS

TY  - JOUR
TI  - Comparing Alternative Ranibizumab Dosages for Safety and Efficacy in Retinopathy of Prematurity
AU  - Andreas Stahl
AU  - Tim U. Krohne
AU  - Nicole Eter
AU  - Isabel Oberacher-Velten
AU  - Rainer Guthoff
AU  - Synke Meltendorf
AU  - Oliver Ehrt
AU  - Sabine Aisenbrey
AU  - Johann Roider
AU  - Heinrich Gerding
AU  - Claudia Jandeck
AU  - Lois E. H. Smith
AU  - Johanna M. Walz
AU  - Unknown
PY  - 2018
JO  - JAMA Pediatrics
DO  - 10.1001/jamapediatrics.2017.4838
UR  - https://doi.org/10.1001/jamapediatrics.2017.4838
ER  - 

APA

Stahl, A., Krohne, T. U., Eter, N., Oberacher-Velten, I., Guthoff, R., Meltendorf, S., Ehrt, O., Aisenbrey, S., Roider, J., Gerding, H., Jandeck, C., Smith, L. E. H., Walz, J. M., & Unknown (2018). Comparing Alternative Ranibizumab Dosages for Safety and Efficacy in Retinopathy of Prematurity. JAMA Pediatrics. https://doi.org/10.1001/jamapediatrics.2017.4838

Source records